Lessons from coronary atherosclerosis 'regression' trials

Cardiology Clinics

Volumn 14, Issue 1, 1996, Pages 31-50

  Waters, D ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTIPOL; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; REMISSION; REVIEW; TREATMENT OUTCOME;

EID: 0030038432     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70259-9     Document Type: Article

References (63)

1. E.L. Alderman S.D. Corley L.D. Fisher Five-year angiographic follow-up of coronary artery disease in the Coronary Artery Surgery Study (CASS) J Am Coll Cardiol 22 1993 1141 1154
2. T.J. Anderson I.T. Meredith A.C. Yeung The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion N Engl J Med 332 1995 488 493
3. T.C. Andrews A.P. Selwyn P. Ganz The effect of cholesterol lowering on myocardial ischemia [abstr] Circulation 90 suppl I 1994 I-27
4. M.L. Armstrong M.B. Megan Lipid depletion in atheromatous coronary arteries in rhesus monkeys after regression diets Circ Res 30 1972 675 680
5. G.J. Beauman R.A. Vogel Accuracy of individual and panel visual interpretations of coronary arteriograms: Implications for clinical decisions J Am Coll Cardiol 16 1990 108 113
6. C.E. Bemis R. Gorlin H.G. Kemp Progression of coronary artery disease: A clinical arteriographic study Circulation 47 1973 455 464
7. D.H. Blankenhorn P. Alaupovic E. Wickham Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: Lipid and nonlipid factors Circulation 81 1990 470 476
8. D.H. Blankenhorn S.P. Azen D.M. Kramsch Coronary angiographic changes with lovastatin therapy: The Monitored Atherosclerosis Regression Study (MARS) Ann Intern Med 119 1993 969 976
9. D.H. Blankenhorn S.A. Nessim R.L. Johnson Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts JAMA 257 1987 3233 3240
10. J.F. Brensike R.I. Levy S.F. Kelsey Effects of therapy and cholestyramine on progression of coronary arteriosclerosis: Results of the NHLBI Type II Coronary Intervention Study Circulation 69 1984 313 324
11. B.G. Brown E.L. Bolson H.T. Dodge Arteriographic assessment of coronary atherosclerosis: Review of current methods, their limitations, and clinical applications Arteriosclerosis 2 1982 1 15
12. B.G. Brown E. Bolson M. Frimer Quantitative coronary arteriography: Estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation Circulation 55 1977 329 337
13. G. Brown J.J. Albers L.D. Fisher Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B N Engl J Med 323 1990 1289 1298
14. A.V.G. Bruschke T. Wijers W. Kolsters The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients Circulation 63 1981 527 536
15. H. Buchwald J.P. Matts L.L. Fitch Changes in sequential coronary arteriograms and subsequent coronary events JAMA 268 1992 1429 1433
16. H. Buchwald R.L. Varco J.P. Matts Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia N Engl J Med 323 1990 946 955
17. L. Campeau M. Enjalbert J. Lespérance The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation N Engl J Med 311 1984 1329 1332
18. L. Cashin-Hemphill W.J. Mack J.M. Pogoda Beneficial effects of colestipol-niacin on coronary atherosclerosis: A 4-year follow-up JAMA 264 1990 3013 3017
19. T.A. DeRouen J.A. Murray W. Owen Variability in the analysis of coronary arteriograms Circulation 55 1977 324 328
20. K.M. Detre S.F. Kelsey E.R. Passamani Reliability of assessing change with sequential coronary angiography Am Heart J 104 1982 816 823
21. M.A. De Wood W.F. Sifter C.S. Simpson Coronary arteriographic findings soon after non-Q-wave myocardial infarction N Engl J Med 315 1986 417 423
22. M.A. De Wood J. Spores R. Notske Prevalence of total coronary occlusion during the early hours of transmural infarction N Engl J Med 303 1980 897 902
23. B. Fendley B. Stewart G. Brown Coronary atherosclerosis regression is less pronounced during a second course of comparable effective lipid-lowering therapy [abstr] Circulation 88 suppl I 1993 I-363
24. V. Fuster J.J. Badimon L. Badimon Clinical-pathological correlations of coronary disease progression and regression Circulation 86 suppl III 1992 III-1 III-11
25. C.M. Gibson B. Rosner L. Hillger A comparison of outcomes and sample sizes using lesion and patient-based analyses of coronary regression data: Results of the Familial Atherosclerosis Treatment Study (FATS) [abstr] J Am Coll Cardiol 21 suppl A 1993 21A
26. C.M. Gibson T. Sandor P.H. Stone Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials Am J Cardiol 69 1992 1286 1290
27. E. Glassman F.C. Spencer K.R. Krauss Changes in the underlying coronary circulation secondary to bypass grafting Circulation 49,50 suppl II 1974 II-80 II-96
28. K.L. Gould J.P. Martucci D.I. Goldberg Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: A potential noninvasive marker of healing coronary endothelium Circulation 89 1994 1530 1538
29. K.L. Gould D. Ornish R. Kirkeeide Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modifications Am J Cardiol 69 1992 845 853
30. W.L. Haskell E.L. Alderman J.M. Fair Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP) Circulation 89 1994 975 990
31. D.B. Hunninghake E. Stein C.A. Dujovne The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia N Engl J Med 328 1993 1213 1219
32. S. Jost J.W. Deckers P. Nikutta Progression of coronary artery disease is dependent on anatomic location and diameter J Am Coll Cardiol 21 1993 1339 1346
33. J.P. Kane M.J. Malloy T.A. Ports Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens JAMA 264 1990 3007 3012
34. J.R. Kramer Y. Matsuda J.C. Mulligan Progression of coronary atherosclerosis Circulation 63 1981 519 526
35. J. Lespérance D. Waters Measuring progression and regression of coronary atherosclerosis in clinical trials: Problems and progress Int J Card Imaging 8 1992 165 173
36. R.I. Levy J.F. Brensike S.E. Epstein The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: Results of the NHLBI Type II Coronary Intervention Study Circulation 69 1984 325 337
37. P.R. Lichtlen P. Nikutta S. Jost Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitative coronary angiography: Relation to clinical events and risk factors Circulation 86 1992 828 838
38. MAAS Investigators Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS) Lancet 344 1994 633 638
39. B.G.J. Mancini S.B. Simon M.J. McGillem Automated quantitative coronary arteriography: Morphologic and hoysiologic validation in vivo of a rapid digital angiographic method Circulation 75 1987 452 460
40. B.J. Maurer A. Oberman J.H. Holt Changes in grafted and nongrafted coronary arteries following saphenous vein bypass grafting Circulation 50 1974 293 300
41. A. Moise J. Lespérance P. Théroux Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: Analysis of 313 nonoperated patients Am J Cardiol 54 1984 1176 1181
42. A. Moise P. Théroux Y. Taeymans Unstable angina and progression of coronary atherosclerosis N Engl J Med 309 1983 685 689
43. A. Moise P. Théroux Y. Taeymans Clinical and angiographic factors associated with progression of coronary artery disease J Am Coll Cardiol 3 1984 659 667
44. D. Ornish S. Brown L.W. Scherwitz Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial Lancet 336 1990 129 133
45. N.R. Phillips D. Waters R.J. Havel Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events Circulation 88 1993 2762 2770
46. B. Pitt G.B.J. Mancini S.G. Ellis Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-1): Reduction in atherosclerosis progression and clinical events J Am Coll Cardiol 26 1995 1133 1139
47. T.G. Quinn E.L. Alderman A. McMillan Development of new coronary atherosclerotic lesions during a 4-year multifactor risk reduction program: The Stanford Coronary Risk Intervention Project (SCRIP) J Am Coll Cardiol 24 1994 900 908
48. J.S. Raichlen B. Healy S.C. Achuff Importance of risk factors in the angiographic progression of coronary artery disease Am J Cardiol 57 1986 66 70
49. J.H.C. Reiber C.J. Kooijman C.J. Slager Coronary artery dimensions from cineangiograms—methodology and validation of a computer-assisted analysis procedure IEEE Trans Med Imag MI- 3 1984 131 140
50. J.H.C. Reiber P.W. Serruys C.J. Kooijman Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms Circulation 71 1985 280 288
51. F.M. Sacks R.C. Pasternak C.M. Gibson Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients Lancet 344 1994 1182 1186
52. M.E. Sanmarco S.H. Brooks D.H. Blankenhorn Reproducibility of a consensus panel in the interpretation of coronary angiograms Am Heart J 96 1978 430 437
53. Scandinavian Simvastatin Survival Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
54. G. Schuler R. Hambrecht G. Schlierf Regular physical exercise and low fat diet—effect on progression of coronary artery disease Circulation 86 1992 1 11
55. S. Shea R.R. Sciacca P. Esser Progression of coronary atherosclerotic disease assessed by cinevideodensitometry: Relation to clinical risk factors J Am Coll Cardiol 8 1986 1325 1331
56. C.B. Treasure J.L. Klein W.S. Weintraub Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease N Engl J Med 332 1995 481 487
57. J. Vanhaecke J. Piessens F. Van de Werf Angiographic evolution of coronary atherosclerosis in nonoperated patients Eur Heart J 4 1983 547 556
58. D. Waters T.E. Craven J. Lespérance Prognostic significance of progression of coronary atherosclerosis Circulation 87 1993 1067 1075
59. D. Waters L. Higginson P. Gladstone Effects of monotherapy with an HMG CoA redutase inhibitor upon the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: The Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Circulation 89 1994 959 968
60. D. Waters J. Lespérance M. Francetich A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis Circulation 82 1990 1940 1953
61. D. Waters J. Lespérance L. Higginson Effect of monotherapy with an HMG Co A reductase inhibitor on the development of new coronary lesions: A CCAIT substudy [abstr] Circulation 90 suppl I 1994 I-489
62. G.F. Watts B. Lewis J.N.H. Brunt Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS) Lancet 339 1992 565 569
63. L.M. Zir S.W. Miller R.E. Dinsmore Interobserver variability in coronary angiography Circulation 53 1976 627 632